<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> has been reported to have beneficial effects against ischemic brain damage, although the mechanisms are not fully clarified </plain></SENT>
<SENT sid="1" pm="."><plain>To examine the role of <z:chebi fb="3" ids="16335">adenosine</z:chebi> on the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked release of <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi>, we applied a highly selective <z:chebi fb="4" ids="48705">agonist</z:chebi> for <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptor, 2-chloro-N6-cyclopentyladenosine (CCPA), into the ischemic brain using in vivo brain dialysis, which directly delivered the <z:chebi fb="4" ids="48705">agonist</z:chebi> to the local brain area </plain></SENT>
<SENT sid="2" pm="."><plain>Concentrations of extracellular amino acids (<z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="0" ids="29995">aspartate</z:chebi>, <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> (<z:chebi fb="3" ids="16865">GABA</z:chebi>) and <z:chebi fb="5" ids="15891">taurine</z:chebi>) and regional blood flow in the striatum of spontaneously hypertensive rats (SHRs) were monitored during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> elicited by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 40 min and recirculation </plain></SENT>
<SENT sid="3" pm="."><plain>Striatal blood flow and basal levels of amino acids were not affected by direct perfusion of CCPA (10 microM or 100 microM) </plain></SENT>
<SENT sid="4" pm="."><plain>During <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, concentrations of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="0" ids="29995">aspartate</z:chebi>, <z:chebi fb="3" ids="16865">GABA</z:chebi> and <z:chebi fb="5" ids="15891">taurine</z:chebi> increased up to 37-, 30-, 96- and 31-fold, respectively, when vehicle alone was administered </plain></SENT>
<SENT sid="5" pm="."><plain>Administration of CCPA did not affect the changes in regional blood flow during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>Perfusion of CCPA (100 microM), however, significantly attenuated the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked release of <z:chebi fb="0" ids="29995">aspartate</z:chebi> (by 70%) and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> (by 73%) </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increase of <z:chebi fb="3" ids="16865">GABA</z:chebi> tended to be decreased by CCPA, although it was not statistically significant </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, both low and high concentrations of CCPA had little effect on the release of <z:chebi fb="5" ids="15891">taurine</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that stimulation of <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptors selectively attenuated the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked release of excitatory amino acids, but not of inhibitory amino acids without affecting blood flow </plain></SENT>
<SENT sid="10" pm="."><plain>This modulation of the release of amino acids by <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptor <z:chebi fb="4" ids="48705">agonists</z:chebi> may play a protective role against ischemic neuronal damage </plain></SENT>
</text></document>